Results 131 to 140 of about 55,084 (278)

The Value of Information Technology-Enabled Diabetes Management [PDF]

open access: yes, 2007
Reviews different technologies used in diabetes disease management, as well as the costs, benefits, and quality implications of technology-enabled diabetes management programs in the United ...
Blackford Middleton   +9 more
core  

Obesity‐related glomerulopathy: How it happens and future perspectives

open access: yesDiabetic Medicine, Volume 42, Issue 6, June 2025.
Abstract Obesity‐related glomerulopathy (ORG) is an emerging complication of excess adiposity. Its incidence rises alongside the obesity pandemic. Up to 40% of individuals can be affected by ORG, irrespective of the status of glomerular filtration rate and albuminuria.
Jian‐Wen Samuel Lee‐Boey   +7 more
wiley   +1 more source

Microalbuminuria: associations with height and sex in non-diabetic subjects. [PDF]

open access: bronze, 1993
Mairi Gould   +4 more
openalex   +1 more source

Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin‐deficient phenotype: A real world analysis

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3176-3184, June 2025.
Abstract Aim Diabetic kidney disease (DKD) is a major complication of diabetes, including in insulin‐deficient phenotypes, yet data on kidney outcomes with sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in this population are limited. This study investigates the impact of SGLT2i on kidney outcomes in patients with insulin‐deficient diabetes using ...
Anat Tsur   +3 more
wiley   +1 more source

Clinically meaningful improvements in treatment satisfaction in insulin‐naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real‐world ATOS study

open access: yes
Diabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 4011-4016, July 2025.
Frank Snoek   +11 more
wiley   +1 more source

Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 2920-2939, June 2025.
Abstract Glycaemic therapy in type 1 diabetes (T1D) is focused on insulin, with the majority of studies investigating different insulin preparations, delivery devices and dosing accuracy methods. While insulin deficiency is the key mechanism for hyperglycaemia in T1D, individuals with this condition can also develop insulin resistance (IR), making ...
Ahmad M. Rajab   +2 more
wiley   +1 more source

Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3201-3211, June 2025.
Abstract Background and aim We assessed the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) and significant liver fibrosis in adults with type 1 diabetes mellitus (T1DM) and the association of MASLD with insulin sensitivity and continuous glucose monitoring metrics.
Michela Vergani   +12 more
wiley   +1 more source

Microalbuminuria in chronic obstructive lung disease. [PDF]

open access: bronze, 1993
Robert J. Wilkinson   +2 more
openalex   +1 more source

Microalbuminuria, height, and sex. [PDF]

open access: green, 1993
Paul McKeigue, David A. Leon
openalex   +1 more source

Home - About - Disclaimer - Privacy